PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
42.82
ESG score below 80% of Biotechnology median of 59.51. Michael Burry would check for potential stranded assets and regulatory compliance issues.
50.00
Environmental score 80-90% of Biotechnology median of 55.98. Martin Whitman would look for hidden carbon liabilities and stranded asset risks.
29.13
Social score below 80% of Biotechnology median of 59.78. Michael Burry would check for potential boycott risks and regulatory compliance issues.
49.33
Governance score 80-90% of Biotechnology median of 61.14. Martin Whitman would look for hidden agency costs and management entrenchment risks.